AI and dye join forces to spot leaky gut in IBD patients
NCT ID NCT07546955
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new imaging system that uses a fluorescent dye and artificial intelligence during colonoscopy to measure how leaky the gut lining is in people with inflammatory bowel disease (IBD). It includes 70 adults (60 with IBD and 10 without) at three Canadian hospitals. The main goal is to see if the procedure is safe and can produce usable measurements. This is an early-stage study to gather data, not a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (CROHN'S DISEASE; ULCERATIVE COLITIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Rewiring the immune system: a new hope for children with severe IBD?
- Vitamin d may unlock iron absorption in IBD patients
- Can a structured chat with a nurse boost medication adherence in IBD?
- Can a 2-Hour online class ease IBD pain?
- Ear zap for IBD? tiny study tests nerve stimulation for gut relief
- Why do kids with IBD avoid exercise? a new study aims to find out